Hemex
Europe, Basel-Landschaft, Switzerland, Liestal
Description
Hemex AG helps its clients to develop pharmaceuticals and medical devices.
Investor Profile
Hemex has backed more than 14 startups, with 1 new investments in the last 12 months alone. The firm has led 6 rounds, about 43% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in Switzerland, Sweden.
- Strong thematic focus on Health Care, Biotechnology, Life Science.
- Led 1 rounds in the past year.
Stage Focus
- Seed (43%)
- Series A (21%)
- Series B (14%)
- Convertible Note (7%)
- Pre Seed (7%)
- Series Unknown (7%)
Country Focus
- Switzerland (93%)
- Sweden (7%)
Industry Focus
- Health Care
- Biotechnology
- Life Science
- Medical Device
- Medical
- Hardware
- Information Technology
- Therapeutics
- Artificial Intelligence (Ai)
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Hemex frequently co-invest with?
Which angels does Hemex often collaborate with?
What are some of recent deals done by Hemex?
Find More Investors Like Hemex
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
